Crossmark

Clinical symptoms and cognitive functioning following adjunctive N-acetylcysteine in obsessive-compulsive disorder: a double-blind, placebo-controlled trial

Crossref DOI link: https://doi.org/10.1038/s43856-026-01711-6

Published Online: 2026-06-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Askari, Sanaz

Eghdami, Shayan https://orcid.org/0000-0001-8762-2184
Tavasoli, Mahla

Shariat, Seyed Vahid

Yarahmadi, Masoomeh

Ghanbari Jolfaei, Atefeh

Shirazi, Elham

Tajik Esmaeeli, Soode

Shalbafan, Mohammadreza https://orcid.org/0000-0002-4536-3441
Funding

Funding for this research was provided by:

Iran University of Medical Sciences (1401-4-99-25244)
License Information

Text and Data Mining valid from 2026-06-08

Accepted Manuscript valid from 2026-06-08
More Information

Article History

Received: 25 June 2025

Accepted: 27 May 2026

First Online: 8 June 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below